Neurodegeneration

Our research goal is to achieve a comprehensive understanding of Alzheimer's disease and other brain diseases; spanning neuroimaging biomarkers, molecular pathways involving the amyloid precursor protein, and leveraging induced pluripotent stem cells for disease modeling, with the ultimate goal of developing innovative regenerative therapies for various neurodegenerative conditions.

Translational Alzheimer imaging biomarker development (Dr. Ruiqing Ni, Group Leader)

Cellular Neurobiology (Dr. Uwe Konietzko, Scientific Head of Division and Group Leader)

Translational Neurodegeneration (PD Dr. Christian Tackenberg, Head of Stem Cell Research and Group Leader)

Clinical Alzheimer Research (PD Dr. Valerie Treyer, Group Leader; Dr. Christoph
Gericke, Group Leader; Dr. Anton Gietl, Clinical Lead)

Prof. em. Christoph Hock, MD